PIM1 and prostate carcinoma: PIM1 has also been linked to a variety of oncogenic processes in both prostate cancer and other cancers, including cell-cycle progression, genomic instability, resistance to chemotherapeutics, and increased tumorigenicity in mouse xenograft models2–6.